• Dicoumarol Inhibits IRE1α to Mitigate ER Stress-Induced Live

  2026-05-24

  A recent study developed a high-throughput strategy combining molecular docking and reporter-based screening to identify dicoumarol as a potent inhibitor of IRE1α, a key unfolded protein response mediator. The findings demonstrate dicoumarol's effectiveness in protecting hepatocytes from ER stress-induced injury, establishing a new framework for therapeutic discovery in liver disease.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): P

  2026-05-23

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide a robust and efficient solution for isolating or purifying biotinylated molecules from complex biological samples, with minimized nonspecific binding. These beads are best suited for workflows requiring rapid, high-specificity capture—such as immunoprecipitation, protein interaction studies, and nucleic acid purification—while applications outside the biotin-streptavidin system or requiring direct mechanistic evidence should be approached with caution.

• Benzyl-Activated Streptavidin Magnetic Beads: Enabling Advan

  2026-05-22

  Explore the unique advantages of Benzyl-activated Streptavidin Magnetic Beads for sensitive biotinylated molecule capture, with deep insight into their role in emerging viral entry research. This article goes beyond standard protocols, revealing advanced applications and mechanistic details.

• Y-27632: ROCK Inhibitor Protocols for Cytoskeletal Modulatio

  2026-05-22

  Y-27632, a selective ROCK inhibitor from APExBIO, empowers researchers to dissect cytoskeletal dynamics and stress fiber regulation in advanced cell models. This article translates leading-edge experimental workflows and troubleshooting strategies into actionable guidance for cancer biology and regenerative research.

• D-Lin-MC3-DMA: Precision Lipid for Next-Gen mRNA Delivery

  2026-05-21

  Explore D-Lin-MC3-DMA as an advanced ionizable cationic liposome for mRNA and siRNA delivery. This article reveals new insights into machine learning-guided LNP design and practical protocol choices that set it apart from existing overviews.

• Iron Stress Alters Enterocyte Metabolism and Inflammatory Si

  2026-05-21

  Navazesh and Ji's 2025 study reveals how both iron deficiency and excess profoundly reshape enterocyte metabolic and inflammatory pathways. Using IPEC-J2 cell models and untargeted metabolomics, the research maps iron-dependent transcriptional, metabolic, and immune effects, informing experimental approaches to intestinal iron homeostasis.

• Fucoidan (C4038): Mechanistic Precision for Cancer and Antiv

  2026-05-20

  Discover how Fucoidan, a sulfated α-L-Fucan, drives precise apoptosis induction and immune modulation in cancer and antiviral models. This deep-dive uniquely analyzes cross-domain mechanisms and the practical impact of recent nuclear egress research.

• hiPSC-Derived Sensory Neurons Model HSV-1 Latency and Reacti

  2026-05-20

  This study establishes a robust system for differentiating human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons, enabling detailed modeling of herpes simplex virus 1 (HSV-1) latent infection and reactivation. The platform overcomes previous limitations of scalability and human relevance, offering new opportunities to investigate neuron-intrinsic mechanisms of HSV-1 latency and potential therapeutic strategies.

• Capsazepine: Precision TRPV1 Antagonist for Pain and Cancer

  2026-05-19

  Explore how Capsazepine, a leading TRPV1 ion channel antagonist, enables advanced interrogation of pain signaling and apoptosis sensitization in cancer cells. This article provides a unique, cross-functional analysis of Capsazepine’s applications, mechanisms, and protocols—bridging translational pain research with oncology insights.

• Resveratrol Suppresses CAF-Driven Growth in Breast Cancer Or

  2026-05-19

  This study demonstrates that resveratrol inhibits both growth and VCAN expression in breast cancer organoids co-cultured with cancer-associated fibroblasts (CAFs), using advanced organoid models and proliferation assays. The findings highlight the importance of simulating the tumor microenvironment for evaluating drug efficacy and suggest that targeting CAF-mediated pathways may overcome resistance in breast cancer.

• Practical Solutions with Oligomycin A: Reliable Mitochondria

  2026-05-18

  This article addresses real-world laboratory challenges in mitochondrial bioenergetics and cancer metabolism research, demonstrating how Oligomycin A (SKU A5588) delivers robust, reproducible results. Through scenario-driven Q&A, we detail its role in optimizing apoptosis pathway studies, data interpretation, and workflow efficiency for biomedical researchers.

• Ferrostatin-1 (Fer-1): Optimizing Ferroptosis Assays and Bey

  2026-05-18

  Ferrostatin-1 (Fer-1) delivers precise, nanomolar-level inhibition of iron-dependent oxidative damage, making it indispensable in ferroptosis assay workflows. Applied insights from recent nanomaterial studies and cross-model research reveal how to maximize selectivity, reproducibility, and translational value with Fer-1.

• Ferrostatin-1 (Fer-1): Advanced Inhibitor Strategies for Fer

  2026-05-17

  Explore the advanced use of Ferrostatin-1 (Fer-1) as a potent ferroptosis inhibitor in cancer and neurodegenerative disease models. This article reveals unique assay design insights and mechanistic advances that set your research apart.

• QPRT Enhances Breast Cancer Invasion via PLC-Dependent Pathw

  2026-05-16

  Liu et al. reveal that quinolinate phosphoribosyltransferase (QPRT) upregulation drives breast cancer cell invasiveness through a pathway involving myosin light chain phosphorylation and phospholipase C (PLC) signaling. Their work clarifies the mechanistic link between NAD+ metabolism and cytoskeletal regulation, highlighting PLC inhibition as a promising approach for modulating tumor progression.

• AO/PI Staining Solution: Mechanistic Rigor for Translational

  2026-05-15

  Explore how AO/PI Staining Solution empowers translational researchers with precise, mechanistically informed cell viability data. This article bridges molecular insight, competitive benchmarking, and actionable guidance—anchored in the latest findings on inflammation and apoptosis in diabetic nephropathy—to establish new standards for fluorescence-based cell counting in disease modeling and drug discovery.

444 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page